Literature DB >> 15971310

Carbon ion radiation therapy for chordomas and low grade chondrosarcomas--current status of the clinical trials at GSI.

Daniela Schulz-Ertner1, Anna Nikoghosyan, Bernd Didinger, Jürgen Debus.   

Abstract

Carbon ion radiation therapy (RT) is available at the German Ion Research Center (GSI) in Darmstadt, Germany, since December 1997. Patient treatments within the pilot project are carried out by radiation oncologists of the University of Heidelberg in cooperation with the Department of Biophysics of GSI, the Division of Medical Physics of the German Cancer Research Center Heidelberg and the Research Center Rossendorf. Patients are treated within three beam time blocks of 20 days per year at the basic physics research center at GSI, the overall capacity per year being 45 to 50 patients. Main purpose of the pilot project was to investigate carbon ion radiation therapy for different tumor entities within clinical phase I/II trials. This manuscript updates the results of the clinical phase I/II trial of carbon ion RT in chordomas and low grade chondrosarcomas of the skull base and summarizes the current status of the ongoing phase I/II trial for extracranial chordomas and low grade chondrosarcomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15971310     DOI: 10.1016/s0167-8140(04)80014-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

Review 1.  [Advances in radio-oncology. From precision radiotherapy with photons to ion therapy with protons and carbon ions].

Authors:  S E Combs; D Schulz-Ertner; K K Herfarth; R Krempien; J Debus
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

2.  Surgical treatment of skull base chondrosarcomas.

Authors:  Amir Samii; Venelin Gerganov; Christian Herold; Alireza Gharabaghi; Nakamasa Hayashi; Madjid Samii
Journal:  Neurosurg Rev       Date:  2008-09-26       Impact factor: 3.042

3.  Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.

Authors:  Claudia Blattmann; Susanne Oertel; Daniela Schulz-Ertner; Stefan Rieken; Sabine Haufe; Volker Ewerbeck; Andreas Unterberg; Irini Karapanagiotou-Schenkel; Stephanie E Combs; Anna Nikoghosyan; Marc Bischof; Oliver Jäkel; Peter Huber; Andreas E Kulozik; Jürgen Debus
Journal:  BMC Cancer       Date:  2010-03-12       Impact factor: 4.430

4.  Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.

Authors:  Stephanie E Combs; Steffen Heeger; Renate Haselmann; Lutz Edler; Jürgen Debus; Daniela Schulz-Ertner
Journal:  BMC Cancer       Date:  2006-05-18       Impact factor: 4.430

Review 5.  Differential Superiority of Heavy Charged-Particle Irradiation to X-Rays: Studies on Biological Effectiveness and Side Effect Mechanisms in Multicellular Tumor and Normal Tissue Models.

Authors:  Stefan Walenta; Wolfgang Mueller-Klieser
Journal:  Front Oncol       Date:  2016-02-25       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.